Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

NCT02669173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Capecitabine
DRUG: Bevacizumab

Sponsor

Case Comprehensive Cancer Center